Literature DB >> 10729826

Flipping the oncogene switch: illumination of tumor maintenance and regression.

L Chin1, R A DePinho.   

Abstract

The genetic construction of cancer-prone mice, combined with the capacity to control transgene expression in vivo, provides new opportunities to study the role of oncogenes in the maintenance of fully formed tumors. These inducible cancer models provide a means to dissect how specific oncogenic signals influence host-tumor symbiosis, to validate the importance of a given oncogenic lesion in established advanced tumors, and to predict the biological response and adaptations to therapies targeted to that cancer-causing genetic alteration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729826     DOI: 10.1016/s0168-9525(99)01968-x

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  5 in total

1.  Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma.

Authors:  Jinu Abraham; Suresh I Prajapati; Koichi Nishijo; Beverly S Schaffer; Eri Taniguchi; Aoife Kilcoyne; Amanda T McCleish; Laura D Nelon; Francis G Giles; Argiris Efstratiadis; Robin D LeGallo; Brent M Nowak; Brian P Rubin; Suman Malempati; Charles Keller
Journal:  Mol Cancer Ther       Date:  2011-03-29       Impact factor: 6.261

2.  KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.

Authors:  Rónán C O'Hagan; Joerg Heyer
Journal:  Genes Cancer       Date:  2011-03

3.  Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.

Authors:  Michael T Debies; Shelley A Gestl; Jessica L Mathers; Oliver R Mikse; Travis L Leonard; Susan E Moody; Lewis A Chodosh; Robert D Cardiff; Edward J Gunther
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

4.  Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.

Authors:  R Wang; L D Ferrell; S Faouzi; J J Maher; J M Bishop
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

5.  Transgene design.

Authors:  Bart van de Sluis; Jan Willem Voncken
Journal:  Methods Mol Biol       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.